Kukje Pharmaceutical Industrial Co. Ltd. announces an Equity Buyback for 300,000 shares.
November 01, 2016
Share
Kukje Pharmaceutical Industrial Co. Ltd. (KOSE:A002720) announces a share repurchase program. Under the program, the company will repurchase up to 300,000 shares for KRW 1,177.5 million, which is based on the closing price of the shares as on November 1, 2016. The company will repurchase its shares directly through the stock market. The purpose of the program is to stabilize the share price and enhancement of shareholder value. The maximum number of shares that the company may repurchase on any day is 30,000 shares. The program is valid until February 2, 2017. As on November 1, 2016, the company had 596,033 shares in treasury within scope available for dividend and had 1,518 common shares in treasury under other capacities.
Kukje Pharma Co., Ltd, formerly Kukje Pharma Ind. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products are finished products, such as antibiotics, other antibiotics for injection, antifungal and antiviral agents, agents for gastrointestinal tract and liver, muscle relaxants, anti-osteoporotics, corticosteroids, agents for cardiovascular and endocrine systems, ophthalmic agents, remedies for central nervous system (CNS) disorders, remedies for urinary systems, antihistamines, antitussives, cough and cold remedies, non-steroidal anti inflammatory drugs (NSAIDs), antitussive, cough and cold remedies, as well as other over-the-counter (OTC) drugs. It also provides raw materials, such as ceftriaxone sodium sterile, cefuroxime axetil, ceftezole sodium sterile, cefminox sodium sterile, cefuroxime sodium sterile and others.
KUKJE PHARMA CO., LTD. 
